63
|
211
|
8g6fL |
Structure of the plasmodium falciparum 20s proteasome beta-6 a117d mutant complexed with inhibitor wlw-vs |
64
|
215
|
8g6fM |
Structure of the plasmodium falciparum 20s proteasome beta-6 a117d mutant complexed with inhibitor wlw-vs |
83
|
264
|
8g6eN |
Structure of the plasmodium falciparum 20s proteasome complexed with inhibitor tdi-8304 |
55
|
221
|
8g6fI |
Structure of the plasmodium falciparum 20s proteasome beta-6 a117d mutant complexed with inhibitor wlw-vs |
77
|
252
|
8g6eH |
Structure of the plasmodium falciparum 20s proteasome complexed with inhibitor tdi-8304 |
71
|
252
|
8g6fH |
Structure of the plasmodium falciparum 20s proteasome beta-6 a117d mutant complexed with inhibitor wlw-vs |
98
|
388
|
6pz4A |
Co-crystal structure of bace with inhibitor am-6494 |
135
|
323
|
6inkA |
Crystal structure of pde4d complexed with a novel inhibitor |
140
|
325
|
6imdA |
Crystal structure of pde4d complexed with a novel inhibitor |
137
|
325
|
6imrA |
Crystal structure of pde4d complexed with a novel inhibitor |
146
|
368
|
6xdmA |
Structure of human hdac2 in complex with an aryl ketone inhibitor |
167
|
539
|
6ntmA |
Crystal structure of recombinant human acetylcholinesterase inhibited by a-232 in complex with the reactivator, hi-6 |
63
|
168
|
7rpzA |
Kras g12d in complex with mrtx-1133 |
62
|
215
|
6pxfA |
Structure of human cathepsin k with an ectosteric inhibitor at 1.85 angstrom resolution |
50
|
140
|
7rn7A |
Crystal structure of caspase-3 with inhibitor ac-vd(aly)vd-cho |
86
|
306
|
7t3zA |
Structure of mers 3cl protease in complex with inhibitor 9c |
85
|
309
|
7lfuD |
Crystal structure of the sars cov-1 papain-like protease in complex with peptide inhibitor vir250 |
112
|
299
|
7eqzA |
Crystal structure of carboxypeptidase b complexed with potato carboxypeptidase inhibitor |
5
|
35
|
7eqzI |
Crystal structure of carboxypeptidase b complexed with potato carboxypeptidase inhibitor |
17
|
92
|
7rn7B |
Crystal structure of caspase-3 with inhibitor ac-vd(aly)vd-cho |
83
|
306
|
7tq7A |
Structure of mers 3cl protease in complex with the cyclopropane based inhibitor 13c |
83
|
297
|
7tq6A |
Structure of sars-cov-2 3cl protease in complex with the cyclopropane based inhibitor 13d |
84
|
298
|
7tq5A |
Structure of sars-cov-2 3cl protease in complex with the cyclopropane based inhibitor 10d |
87
|
302
|
7u28A |
Structure of sars-cov-2 mpro lambda (g15s) in complex with nirmatrelvir (pf-07321332) |
83
|
305
|
7u29A |
Structure of sars-cov-2 mpro mutant (k90r) in complex with nirmatrelvir (pf-07321332) |
85
|
305
|
7tq8A |
Structure of mers 3cl protease in complex with the cyclopropane based inhibitor 14d |
89
|
310
|
7tzjA |
Sars cov-2 plpro in complex with inhibitor 3k |
85
|
302
|
7tllA |
Structure of sars-cov-2 mpro omicron p132h in complex with nirmatrelvir (pf-07321332) |
93
|
262
|
7s0vA |
The role of an asp-asp pair in the structure, function and inhibition of ctx-m class a beta-lactamase |
49
|
180
|
7s7lB |
Complex of tissue inhibitor of metalloproteinases-1 (timp-1) mutant (l34g/m66s/e67y/l133n/s155l) with matrix metalloproteinase-3 catalytic domain (mmp-3cd) |
45
|
165
|
7s7lA |
Complex of tissue inhibitor of metalloproteinases-1 (timp-1) mutant (l34g/m66s/e67y/l133n/s155l) with matrix metalloproteinase-3 catalytic domain (mmp-3cd) |
97
|
336
|
7mgtA |
Ftp from treponema pallidum bound to an adp-like inhibitor |
39
|
179
|
7s7mB |
Complex of tissue inhibitor of metalloproteinases-1 (timp-1) mutant (l34g/m66d/t98g/p131s/q153n) with matrix metalloproteinase-3 catalytic domain (mmp-3cd) |
41
|
160
|
7s7mA |
Complex of tissue inhibitor of metalloproteinases-1 (timp-1) mutant (l34g/m66d/t98g/p131s/q153n) with matrix metalloproteinase-3 catalytic domain (mmp-3cd) |
83
|
241
|
7jhqA |
Oxa-48 bound by compound 2.3 |
134
|
324
|
6imbA |
Crystal structure of pde4d complexed with a novel inhibitor |
135
|
323
|
6inmA |
Crystal structure of pde4d complexed with a novel inhibitor |
135
|
324
|
6imoA |
Crystal structure of pde4d complexed with a novel inhibitor |
140
|
325
|
6im6A |
Crystal structure of pde4d complexed with a novel inhibitor |
57
|
192
|
7mk5A |
Crystal structure of escherichia coli clpp covalently inhibited by clipibicyclene |
86
|
257
|
7mlpA |
Crystal structure of ricin a chain in complex with 5-(2,6-dimethylphenyl)thiophene-2-carboxylic acid |
140
|
325
|
6imiA |
Crystal structure of pde4d complexed with a novel inhibitor |
138
|
325
|
6indA |
Crystal structure of pde4d complexed with a novel inhibitor |
88
|
256
|
7mltA |
Crystal structure of ricin a chain in complex with 5-(2-ethylphenyl)thiophene-2-carboxylic acid |
136
|
324
|
6imtA |
Crystal structure of pde4d complexed with a novel inhibitor |
91
|
258
|
7mlnA |
Crystal structure of ricin a chain in complex with 5-(o-tolyl)thiophene-2-carboxylic acid |
87
|
260
|
7mloA |
Crystal structure of ricin a chain in complex with 5-mesitylthiophene-2-carboxylic acid |
123
|
317
|
7k4gA |
Human arginase 1 in complex with compound 01. |
125
|
317
|
7k4jA |
Human arginase 1 in complex with compound 51. |
85
|
242
|
7k5vA |
Oxa-48 bound by compound 3.1 |